David R. Bauer
Lawyers
Filters
Ayala Pharmaceuticals $20 million at-the-market offering
We advised the sales agent on the stock offering
Charles River Laboratories acquisition of Vigene Biosciences
We are advising Charles River on the acquisition
AgileThought to combine with LIV Capital Acquisition Corp. and list on Nasdaq
We advised the SPAC on the transaction
ImmunityBio $500 million at-the-market offering
We advised the sales agent in connection with the equity offering
Vaccitech $110.5 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Roivant Sciences combination with Montes Archimedes Acquisition
We are advising Roivant Sciences on its combination with a SPAC
NeuroPace $102 million IPO
We advised the underwriters in connection with the IPO and Nasdaq listing
Akoya Biosciences $151.3 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Ionis Pharmaceuticals $632.5 million convertible senior notes offering
We advised the purchasers on the Rule 144A convertible notes offering
Maravai LifeSciences $646.9 million secondary offering
We advised the joint book-running managers on the equity offering